XNASPDCO
Market cap2.72bUSD
Jan 10, Last price
30.81USD
1D
-0.13%
1Q
49.27%
Jan 2017
-24.91%
Name
Patterson Companies Inc
Chart & Performance
Profile
Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
IPO date
Sep 01, 1992
Employees
7,600
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑04 | 2023‑04 | 2022‑04 | 2021‑04 | 2020‑04 | 2019‑04 | 2018‑04 | 2017‑04 | 2016‑04 | 2015‑04 | |
Income | ||||||||||
Revenues | 6,568,272 1.50% | 6,471,471 -0.43% | 6,499,405 9.93% | |||||||
Cost of revenue | 5,188,030 | 5,107,594 | 5,217,585 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 1,380,242 | 1,363,877 | 1,281,820 | |||||||
NOPBT Margin | 21.01% | 21.08% | 19.72% | |||||||
Operating Taxes | 57,534 | 63,563 | 64,540 | |||||||
Tax Rate | 4.17% | 4.66% | 5.04% | |||||||
NOPAT | 1,322,708 | 1,300,314 | 1,217,280 | |||||||
Net income | 185,931 -10.42% | 207,557 2.14% | 203,210 30.28% | |||||||
Dividends | (98,333) | (101,346) | (101,111) | |||||||
Dividend yield | 4.07% | 3.82% | 3.34% | |||||||
Proceeds from repurchase of equity | (229,508) | (55,492) | (35,000) | |||||||
BB yield | 9.51% | 2.09% | 1.15% | |||||||
Debt | ||||||||||
Debt current | 341,565 | 109,390 | 58,348 | |||||||
Long-term debt | 546,654 | 614,373 | 604,566 | |||||||
Deferred revenue | (119,143) | |||||||||
Other long-term liabilities | 141,075 | 37,529 | 31,026 | |||||||
Net debt | 607,437 | 404,072 | 381,718 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (789,378) | (754,852) | (980,994) | |||||||
CAPEX | (67,626) | (64,220) | (38,308) | |||||||
Cash from investing activities | 959,543 | 901,567 | 1,239,028 | |||||||
Cash from financing activities | (215,905) | (126,484) | (253,234) | |||||||
FCF | 1,295,780 | 1,166,099 | 1,219,407 | |||||||
Balance | ||||||||||
Cash | 114,462 | 159,669 | 142,014 | |||||||
Long term investments | 166,320 | 160,022 | 139,182 | |||||||
Excess cash | ||||||||||
Stockholders' equity | 743,053 | 885,829 | 842,115 | |||||||
Invested Capital | 1,905,747 | 1,829,061 | 1,663,895 | |||||||
ROIC | 70.83% | 74.45% | 71.87% | |||||||
ROCE | 72.43% | 70.01% | 71.84% | |||||||
EV | ||||||||||
Common stock shares outstanding | 93,679 | 97,815 | 98,514 | |||||||
Price | 25.77 -4.94% | 27.11 -11.89% | 30.77 -8.04% | |||||||
Market cap | 2,414,108 -8.96% | 2,651,765 -12.52% | 3,031,276 -6.28% | |||||||
EV | 3,022,133 | 3,057,837 | 3,413,953 | |||||||
EBITDA | 1,468,398 | 1,447,581 | 1,363,812 | |||||||
EV/EBITDA | 2.06 | 2.11 | 2.50 | |||||||
Interest | 44,910 | 33,636 | 20,288 | |||||||
Interest/NOPBT | 3.25% | 2.47% | 1.58% |